• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ANI Pharmaceuticals Inc

+ Add to Watchlist

ANIP:US

28.6200 USD 1.9000 6.23%

As of 14:16:20 ET on 07/28/2014.

Snapshot for ANI Pharmaceuticals Inc (ANIP)

Open: 30.5000 Day's Range: 28.1200 - 30.7600 Volume: 202,223
Previous Close: 30.5200 52wk Range: 5.9900 - 38.7360 1-Yr Rtn: +293.00%

Stock Chart for ANIP

No chart data available.
  • ANIP:US 28.6500
  • 1D
  • 1M
  • 1Y
30.5200
Interactive ANIP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANIP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 20.2245
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.4764
Est. EPS (USD) (12/2014) 1.4700
Est. PEG Ratio -
Market Cap (M USD) 335.77
Shares Outstanding (M) 11.28
30 Day Average Volume 185,937
Price/Book (mrq) 3.5102
Price/Sale (ttm) 3.4307
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/04/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANIP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ANIP

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company develops, manufactures and markets branded and generic prescription pharmaceuticals. ANI manufactures oral solid dose products, as well as liquids and topicals.

Robert E Brown JrChairmanArthur S PrzybylPresident/CEO
Charlotte C ArnoldVP/CFORobert SchrepferVP:Business Development
More Company Profile & Key Executives for ANIP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil